|4Apr 18, 4:30 PM ET

Glass Mitchell 4

4 · TNF Pharmaceuticals, Inc. · Filed Apr 18, 2025

Insider Transaction Report

Form 4
Period: 2025-04-17
Glass Mitchell
DirectorDirector, Chief Medical Off.
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2025-04-17+125,000125,000 total
    Exercise: $0.18From: 2025-04-18Exp: 2035-04-16Common Stock (125,000 underlying)
Footnotes (1)
  • [F1]The stock options are subject to expiration if the employment of the Reporting Person is terminated.

Documents

1 file
  • 4
    ownership.xmlPrimary